CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total	Total Stockholders' Equity	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Distributions in excess of accumulated earnings	Non-controlling Interests	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjustment Total Stockholders' Equity	Cumulative Effect, Period of Adoption, Adjustment Distributions in excess of accumulated earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Impact of adoption of ASC 842	$ 1,240,934	$ 1,233,137		$ 919	$ 2,031,967	$ 4,582	$ (804,331)	$ 7,797	$ (87)	$ (87)	$ (87)
Beginning Balance (in shares) at Dec. 31, 2018				91,963,532
Beginning balance at Dec. 31, 2018	1,240,934	1,233,137		$ 919	2,031,967	4,582	(804,331)	7,797	(87)	(87)	(87)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Impact of adoption of ASC 842	1,221,233	1,213,502		$ 922	2,039,269	2,163	(828,852)	7,731	$ (87)	$ (87)	$ (87)
Common stock issued through distribution reinvestment plan (in shares)				345,245
Common stock issued through distribution reinvestment plan	6,983	6,983		$ 3	6,980
Share-based compensation, net	322	322			322
Distributions declared on common stock	(19,323)	(19,323)					(19,323)
Preferred stock dividends	0
Distributions to non-controlling interest holders	(85)							(85)
Other comprehensive income	(2,419)	(2,419)				(2,419)
Net loss	(5,092)	(5,111)					(5,111)	19
Ending Balance (in shares) at Mar. 31, 2019				92,308,777
Ending balance at Mar. 31, 2019	1,221,233	1,213,502		$ 922	2,039,269	2,163	(828,852)	7,731
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Impact of adoption of ASC 842	1,221,233	1,213,502		922	2,039,269	2,163	(828,852)	7,731
Impact of adoption of ASC 842	1,106,744	1,101,334	$ 16	$ 923	2,078,628	(7,043)	(971,190)	5,410
Beginning Balance (in shares) at Dec. 31, 2019			1,610,000	92,356,664
Beginning balance at Dec. 31, 2019	1,106,744	1,101,334	$ 16	$ 923	2,078,628	(7,043)	(971,190)	5,410
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Impact of adoption of ASC 842	$ 1,021,172	1,015,935	$ 16	$ 920	2,074,745	(44,308)	(1,015,438)	5,237
Common stock issued through distribution reinvestment plan (in shares)	400,000			361,053
Common stock issued through distribution reinvestment plan	$ 6,322	6,322		$ 4	6,318
Common stock repurchases (in shares)				(705,101)
Common stock repurchases	(10,546)	(10,546)		$ (7)	(10,539)
Share-based compensation, net	338	338			338
Distributions declared on common stock	(19,504)	(19,504)					(19,504)
Preferred stock dividends	(742)	(742)					(742)
Distributions to non-controlling interest holders	(86)							(86)
Unrealized loss on designated derivative	(37,265)	(37,265)				(37,265)
Net loss	(24,089)	(24,002)					(24,002)	(87)
Ending Balance (in shares) at Mar. 31, 2020			1,610,000	92,012,616
Ending balance at Mar. 31, 2020	1,021,172	1,015,935	$ 16	$ 920	2,074,745	(44,308)	(1,015,438)	5,237
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Impact of adoption of ASC 842	$ 1,021,172	$ 1,015,935	$ 16	$ 920	$ 2,074,745	$ (44,308)	$ (1,015,438)	$ 5,237